| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and President | CEO &President
1 company
Butler John P. is a CEO and President at AKBA. Recent filings cover 2 purchases and 21 sales. Those positions are worth an estimated $2.3M at current prices.
Our model assigns Butler John P. a middling insider score of 61/100, based on 11 past trades. Over a 12-month horizon, 54.5% of those trades were profitable, with an average 12-month return of +6.4%.
Butler John P.'s largest disclosed position is in AKBA as CEO and President, worth about $2.3M. The recent filings there lean toward selling, a net 807,111 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | AKBA Akebia Therapeutics, Inc. | CEO and President | Buy | 69,270 | $1.25 | $86,587.50 | +2.1% | -24.8% | - | |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell10b5-1 | 341,305 | $1.39 | $474,413.95 | -9.4% | +8.7% | - | |
| Mar 3, 2025 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell10b5-1 | 46,409 | $1.83 | $84,928.47 | -1.8% | +80.6% | -32.5% | |
| Feb 3, 2025 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell10b5-1 | 144,250 | $2.10 | $302,925.00 | -5.2% | +10.4% | -33.5% | |
| Feb 29, 2024 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell | 46,570 | $1.58 | $73,580.60 | -2.2% | -34.8% | +17.1% | |
| Feb 27, 2024 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell | 37,733 | $1.52 | $57,354.16 | -1.8% | -34.8% | +9.8% | |
| Feb 1, 2024 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell | 46,489 | $1.68 | $78,101.52 | -2.1% | -27.5% | +31.0% | |
| Mar 1, 2023 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell | 91,868 | $0.88 | $80,614.17 | -5.5% | +4.8% | +72.7% | |
| Feb 27, 2023 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell | 38,632 | $0.81 | $31,415.54 | -2.3% | +17.5% | +101.1% | |
| Mar 1, 2022 | AKBA Akebia Therapeutics, Inc. | CEO and President | Sell | 79,026 | $2.17 | $171,143.40 | -5.3% | -82.8% | -57.4% |